🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Drug development is tough, especially in psychedelics. But not for Dr. Velichka Valcheva. Learn more about how she's pushed GH Research to success in this podcast episode: rtwfunds.com/news-events/in… #biotech #investment #mentalhealth

RTW interns are curious, passionate, and ambitious. Participants in the program get to collaborate with domain experts and experience one-on-one mentoring. #lifesciences #biotech #investment

When developing their treatment, GH Research considered both the needs of the patients and the drug administrator. Learn more from CEO Dr. Velichka Valcheva in this RTW podcast episode: rtwfunds.com/news-events/in… #biotech #investment #mentalhealth

RTW Investments was recently mentioned in BioCentury's article, "Signs of strain and resilience in biotech’s crossover crowd," highlighting our strong position and stability among top #biotech investors in a tough market. Read the full article here: biocentury.com/article/656029…

It's evident that Dr. Velichka Valcheva's mentality has powered GH Research success in helping patients with treatment-resistant depression. Learn more about what she's doing in our podcast episode here: rtwfunds.com/news-events/in… #biotech #investment #mentalhealth

Managing Partner and Chief Investment Officer Rod Wong, MD was recently quoted in Endpoints News article about the GLP-1 market. Read more here: endpoints.news/reality-check-… #obesity #healthcare #biotech

Now that the numbers are out, Dr. Velichka Valcheva's next hurdle is getting GH Research's GH001 treatment through the approval process to patients. Learn more in this RTW podcast episode: rtwfunds.com/news-events/in… #biotech #investment #mentalhealth

How does a biotech investment firm assess new opportunities? Chief Business Officer Stephanie Sirota goes deep into RTW's thought process and research in this Biotech2050 Podcast podcast with Rahul Chaturvedi: biotech2050.com/episodes/steph… #biotech #investment #business

How do you combat stigma around psychedelics as a form of treatment? Dr. Velichka Valcheva, CEO of GH Research, emphasizes the importance of media and how positive coverage can help shift mindsets: linkedin.com/pulse/rtw-podc… #biotech #investment #mentalhealth

One of the most powerful things about GH001 as a depression treatment is its fast-acting nature. Learn more from Dr. Velichka Valcheva, CEO of GH Research, in this RTW podcast episode: rtwfunds.com/news-events/in… #biotech #Investment #mentalhealth

Psychedelics have shown great promise in neuropsychiatric treatment, but their classification as scheduled substances continues to pose challenges. Learn more about how GH Research is dealing with this: rtwfunds.com/news-events/in… #biotech #investment #mentalhealth

President Peter Fong was recently featured in Nature Biotechnology's article on biotech financing. Peter shared his thoughts about the rise of affordable, efficient innovation in the Chinese #biotech market. Read more here: nature.com/articles/s4158…

The rapid effectiveness of GH001 is notable in psychiatric treatment for patients with depression. Learn more about how Dr. Velichka Valcheva, CEO of GH Research, has been working on this drug: rtwfunds.com/news-events/in… #biotech #investment #mentalhealth

"It was a scary moment for the company. A lot has happened since then." Stay tuned for our next podcast episode on July 14, featuring Rod Wong, MD and Andrew Cheng, President and CEO of akerotx, as they discuss MASH, a form of fatty liver disease.

Get to know Senior Research Analyst Chris Liu in our #AboutTheAnalyst series! Chris shares some insights into how his background has shaped his career in this video: youtu.be/2chMl9sYd0Q

Hear from CEOs, investors, and entrepreneurs shaping the future of #biotech on the RTW Podcast. Explore all episodes on our new podcast page: rtwfunds.com/podcasts/?utm_…

For Partner and Research Analyst Joshua Kennedy-Smith, a childhood fascination with nature and science led to a career in organic chemistry. Discover how his curiosity shaped his journey in our #AboutTheAnalyst video here: youtube.com/watch?v=J11pMZ…

Managing Partner and Chief Investment Officer Rod Wong, MD, Senior Research Analyst Niu (Chris) Liu, and Managing Director John Wasilewski recently ran into a famous face while on the go! Any guesses as to who? Comment below! 🏀

"Every other trial had been unsuccessful." Watch our latest RTW Podcast episode, where Rod Wong, MD and akerotx President and CEO Andrew Cheng discuss how Akero pushed forward in MASH, a progressive liver disease, and how their perseverance paid off: rtwfunds.com/podcasts/from-…

MASH, a form of fatty liver disease, affects millions of people worldwide. Learn how akerotx President and CEO Andrew Cheng is working on a treatment in this RTW podcast episode: rtwfunds.com/podcasts/from-… #biotech #investment #healthcare